Those who applied for < Invenia(079950) > hit the daily limit price in just 1 day! Achieved 31% profit!
Congratulations to everyone who applied for the free trial. ^^
※ For those who missed the “COVID-19 treatment,” no worries. We are going out strong once again.
※ Finally starting. Invenia(079950) follow-up stock hits the daily limit price on Wednesday. ※
A domestic company’s research team succeeded in developing a new strain that can be effective in treating ‘pulmonary fibrosis,’ which is known to be deeply related to the novel coronavirus infection, and even registered a patent!!
Green Cross Wellbeing filed a patent on May 22 this year and received registration on September 3, only 3 months later. This is considered to be due to the Korean Patent Office’s expedited registration process, similar to the Korean-style walk-through, reducing the usual patent registration period of over 6 months by more than half!!
“I applied and bought every day for 3 days, and I was amazed to see daily limit price profits every day. It felt like a dream or reality. It’s truly amazing how this could happen. It’s been about 4 months since I paid the membership fee and received VIP service, and already 56 million KRW has accumulated in my account. I’m really grateful for making me earn every day. Ah! I’m also actively recommending it to my acquaintances.”
(VIP office worker Choi Jeong-hoon, 46 years old member)
Think of this as the last chance. If you miss this opportunity, you have to give up.
Exactly on “October 07” it will explode! Don’t miss it and regret it, just buy even with 1 million KRW!
▶▶ Only for 30 people. “Wednesday daily limit price”! ▶ Receive now ◀
※ First-come, first-served for 30 people! Both early and late rounds are over. The hero of the final injury time winning goal ※
[Today’s stocks of interest]
#GreenCrossWellbeing #Bifido #DongwhaPharmaceutical #MyungmoonPharmaceutical #MediforumPharmaceutical
※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

